SUPREP vs Golytely for Colon Cancer Screening

This trial compares two bowel cleansing treatments, Golytely and SUPREP, to determine which is more effective for colon cancer screening in people with diabetes. Researchers aim to identify any differences in bowel cleansing efficacy and patient tolerability between the treatments. Participants will be randomly assigned to use one of the two preparations before their colonoscopy. The trial seeks diabetic adults undergoing routine colon cancer screening with no history of colorectal surgery or inflammatory bowel disease. As a Phase 4 trial, it involves treatments already FDA-approved and proven effective, aiming to understand how they benefit more patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that both Golytely and SUPREP are safe options for bowel cleansing before a colonoscopy. Studies suggest that SUPREP might be more effective and easier to tolerate than Golytely. Both are widely used, and most people tolerate them well.

One study found that SUPREP is less likely to result in an incomplete bowel prep compared to Golytely, making it potentially easier for some people to use. Another study found no major differences in safety between the two. Both are common choices for colonoscopy prep, and serious side effects are rare.

Researchers are excited about these treatments because SUPREP and Golytely offer distinct approaches to bowel preparation for colonoscopy, particularly for diabetic patients. Unlike the standard options, which often include polyethylene glycol solutions like Golytely, SUPREP is sulfate-based, potentially offering a more tolerable taste and better patient compliance. These differences could lead to improved preparation quality and a more comfortable experience for patients, which is crucial for effective colon cancer screening. By exploring these alternatives, researchers hope to enhance the overall effectiveness and acceptance of colonoscopy procedures.

In this trial, diabetic patients will prepare for screening colonoscopy using either SUPREP or Golytely. Previous studies have shown that SUPREP effectively cleans the colon before a colonoscopy. Specifically, research found that patients using SUPREP had a 48% lower chance of an inadequately cleaned colon compared to those using Golytely. This suggests that SUPREP generally prepares the colon better for the procedure. The FDA has approved SUPREP for colon cleansing, supporting its effectiveness. While Golytely is also effective, SUPREP might be easier for patients to tolerate, making it more comfortable to use.¹²³⁴⁶